SecBot SecBot
6-K ·Filed Oct 15, 2026

CUVL

Clinuvel Pharmaceuticals Ltd
NEUTRAL
Impact 2/10
Horizonimmediate Processed12d 15h ago SEC0001493152-26-047083
Notable filing: 6-K
Actionable Insight • Neutral

Routine administrative filing with no trading implications. Monitor future filings for any substantive corporate actions or financial results.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
CUVL ▼ -0.59% at T+5d
NEUTRAL call -0.59% · α vs SPY +0.42% · entry $5.06 → $5.03
Next anchor: T+20d in 15d
Latest observation: T+6 -3.77% FF3 residual α
Entry = T+0 close
Oct 15, 2026
via day close
T+1d
+3.46%
call +3.46% · α +4.57%
$5.24
settled 12d ago
T+5d
-0.59%
call -0.59% · α +0.42%
$5.03
settled 6d ago
T+20d
Pending
in 15d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Clinuvel Pharmaceuticals filed a Form 6-K with the SEC on October 15, 2026, furnishing an Appendix 3H notification of cessation of securities previously filed with the Australian Securities Exchange. The filing is a routine administrative notification of securities cessation with no financial details or material business developments disclosed.

Key Facts

  • Filed Form 6-K on October 15, 2026
  • Furnished Appendix 3H - Notification of cessation of securities as Exhibit 99.1
  • No financial figures, guidance, or material business events disclosed

Financial Impact

No financial impact — routine securities cessation notification with no disclosed amounts

Risk Factors

  • No material risks identified from this filing

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001493152-26-047083
Document: 0001493152-26-047083-index-headers.html0001493152-26-047083
Document: 0001493152-26-047083-index.html0001493152-26-047083
Document: 0001493152-26-047083.txt0001493152-26-047083
8 reports for CUVL
Performance horizon
Filters
Rows
Reports for CUVL — sortable, filterable
TypeNow
Oct 15, 2026
12d ago
6-K
NEUTRAL ★ 2/10
$5.06awaiting T+20—$5.02 (−0.79%)
Oct 7, 2026
20d ago
6-K
NEUTRAL ★ 2/10
$5.80awaiting T+20—$5.02 (−13.45%)
Oct 2, 2026
25d ago
6-K
NEUTRAL ★ 2/10
$6.03awaiting T+20—$5.02 (−16.75%)
Oct 1, 2026
26d ago
6-K
NEUTRAL ★ 3/10
$5.66awaiting T+20—$5.02 (−11.31%)
Aug 27, 2026
8w ago
6-K
NEUTRAL ★ 3/10
$6.77 $5.78▼ −14.62%▼ −14.12%$5.02 (−25.85%)
Aug 27, 2026
8w ago
Press Release
MIXED ★ 5/10
$6.77 $5.78▼ −14.62%▼ −14.12%$5.02 (−25.85%)
Aug 20, 2026
9w ago
6-K
NEUTRAL ★ 2/10
$7.80 $5.90▼ −24.36%▼ −24.36%$5.02 (−35.64%)
Jul 23, 2026
13w ago
6-K
MIXED ★ 5/10
$6.95 $7.80▲ +12.23%▲ +8.92%$5.02 (−27.77%)
Showing 8 of 8

US Market Status

Market Closed — Opens Thu (11h 44m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 15, 2026